93 related articles for article (PubMed ID: 21352989)
1. Topical application of a biodegradable disc with amiodarone for atrial fibrillation.
Takeda T; Shimamoto T; Marui A; Saito N; Uehara K; Minakata K; Miwa S; Nakajima N; Ikeda T; Hyon SH; Sakata R
Ann Thorac Surg; 2011 Mar; 91(3):734-9. PubMed ID: 21352989
[TBL] [Abstract][Full Text] [Related]
2. Invited commentary.
Benussi S
Ann Thorac Surg; 2011 Mar; 91(3):739. PubMed ID: 21352990
[No Abstract] [Full Text] [Related]
3. Atrium-targeted drug delivery through an amiodarone-eluting bilayered patch.
Bolderman RW; Bruin P; Hermans JJ; Boerakker MJ; Dias AA; van der Veen FH; Maessen JG
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):904-10. PubMed ID: 20363485
[TBL] [Abstract][Full Text] [Related]
4. Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study.
Cardona F; Seide H; Cox RA; Pérez CM
P R Health Sci J; 2003 Jun; 22(2):119-23. PubMed ID: 12866134
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
6. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2010 Sep; 7(9):1273-9. PubMed ID: 20478403
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation.
Wang W; Mei YQ; Yuan XH; Feng XD
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):80-5. PubMed ID: 26254755
[TBL] [Abstract][Full Text] [Related]
8. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
[TBL] [Abstract][Full Text] [Related]
10. Impact of amiodarone on electrophysiologic properties of pulmonary veins in patients with paroxysmal atrial fibrillation.
Rostock T; Servatius H; Risius T; Ventura R; Weiss C; Meinertz T; Willems S
J Cardiovasc Electrophysiol; 2005 Jan; 16(1):39-44. PubMed ID: 15673385
[TBL] [Abstract][Full Text] [Related]
11. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
Zapolski T; Wysokiński A
Kardiol Pol; 2005 Sep; 63(3):254-62; discussion 263-4. PubMed ID: 16180181
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation.
Ayers GM; Rho TH; Ben-David J; Besch HR; Zipes DP
J Cardiovasc Electrophysiol; 1996 Aug; 7(8):713-21. PubMed ID: 8856462
[TBL] [Abstract][Full Text] [Related]
13. Epicardial application of an amiodarone-releasing hydrogel to suppress atrial tachyarrhythmias.
Bolderman RW; Hermans JJ; Rademakers LM; de Jong MM; Bruin P; Dias AA; van der Veen FH; Maessen JG
Int J Cardiol; 2011 Jun; 149(3):341-6. PubMed ID: 20202709
[TBL] [Abstract][Full Text] [Related]
14. Topical amiodarone during cardiac surgery: Does epicardial application of amiodarone prevent postoperative atrial fibrillation?
Greenstein D; Beau J; Gottlieb G; Teller D; Kulik A
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):886-892. PubMed ID: 28495063
[TBL] [Abstract][Full Text] [Related]
15. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
Burashnikov A; Di Diego JM; Sicouri S; Ferreiro M; Carlsson L; Antzelevitch C
Heart Rhythm; 2008 Dec; 5(12):1735-42. PubMed ID: 19084813
[TBL] [Abstract][Full Text] [Related]
16. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure.
Kawabata M; Hirao K; Hachiya H; Higuchi K; Tanaka Y; Yagishita A; Inaba O; Isobe M
J Cardiol; 2011 Sep; 58(2):108-15. PubMed ID: 21831597
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
[TBL] [Abstract][Full Text] [Related]
18. A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation: first animal trial.
Beckerman Z; Azran A; Cohen O; Nir RR; Maessen JG; Bianco-Peled H; Bolotin G
J Cardiovasc Pharmacol Ther; 2014 Sep; 19(5):481-91. PubMed ID: 24742769
[TBL] [Abstract][Full Text] [Related]
19. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
Vereckei A; Gorski JC; Ujhelyi M; Mehra R; Zipes DP
Cardiovasc Drugs Ther; 2004 Jul; 18(4):269-77. PubMed ID: 15367824
[TBL] [Abstract][Full Text] [Related]
20. Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years.
Gu S; Su PX; Liu Y; Yan J; Zhang XT; Wang TY
Chin Med J (Engl); 2009 Dec; 122(24):2928-32. PubMed ID: 20137476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
